Prodia Widyahusada Tbk PT
PT Prodia Widyahusada Tbk provides clinical laboratory services primarily in Indonesia. The company offers laboratory, genomic, non-laboratory, and panel test services. It also operates Prodia specialty clinics; and offers vaccination, doctor consultation, and home services. It serves to individuals, doctors, and corporate and partnerships. The company was founded in 1973 and is headquartered in … Read more
Market Cap & Net Worth: Prodia Widyahusada Tbk PT (PRDA)
Prodia Widyahusada Tbk PT (JK:PRDA) has a market capitalization of $141.18 Million (Rp2.30 Trillion) as of March 18, 2026. Listed on the JK stock exchange, this Indonesia-based company holds position #22586 globally and #265 in its home market, demonstrating a 2.08% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Prodia Widyahusada Tbk PT's stock price Rp2450.00 by its total outstanding shares 937500000 (937.50 Million).
Prodia Widyahusada Tbk PT Market Cap History: 2016 to 2026
Prodia Widyahusada Tbk PT's market capitalization history from 2016 to 2026. Data shows change from $254.09 Million to $141.18 Million (-7.44% CAGR).
Index Memberships
Prodia Widyahusada Tbk PT is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Jakarta Stock Exchange Composite Index
JKSE
|
$148.31 Billion | 0.03% | #251 of 864 |
Weight: Prodia Widyahusada Tbk PT's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Prodia Widyahusada Tbk PT Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Prodia Widyahusada Tbk PT's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Prodia Widyahusada Tbk PT's market cap is 0.00 times its annual revenue
0.69x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.00x
Prodia Widyahusada Tbk PT's market cap is 0.00 times its annual earnings
363.13x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $254.09 Million | $1.36 Trillion | $88.13 Billion | 0.00x | 0.00x |
| 2017 | $162.09 Million | $1.47 Trillion | $150.80 Billion | 0.00x | 0.00x |
| 2018 | $101.87 Million | $1.60 Trillion | $175.45 Billion | 0.00x | 0.00x |
| 2019 | $166.39 Million | $1.74 Trillion | $210.26 Billion | 0.00x | 0.00x |
| 2020 | $154.62 Million | $1.87 Trillion | $268.75 Billion | 0.00x | 0.00x |
| 2021 | $456.52 Million | $2.65 Trillion | $623.23 Billion | 0.00x | 0.00x |
| 2022 | $293.73 Million | $2.18 Trillion | $371.65 Billion | 0.00x | 0.00x |
| 2023 | $295.80 Million | $2.22 Trillion | $259.87 Billion | 0.00x | 0.00x |
| 2024 | $155.59 Million | $2.25 Trillion | $270.20 Billion | 0.00x | 0.00x |
Competitor Companies of PRDA by Market Capitalization
Companies near Prodia Widyahusada Tbk PT in the global market cap rankings as of March 18, 2026.
Key companies related to Prodia Widyahusada Tbk PT by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Prodia Widyahusada Tbk PT Historical Marketcap From 2016 to 2026
Between 2016 and today, Prodia Widyahusada Tbk PT's market cap moved from $254.09 Million to $ 141.18 Million, with a yearly change of -7.44%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rp141.18 Million | +6.52% |
| 2025 | Rp132.54 Million | -14.81% |
| 2024 | Rp155.59 Million | -47.40% |
| 2023 | Rp295.80 Million | +0.71% |
| 2022 | Rp293.73 Million | -35.66% |
| 2021 | Rp456.52 Million | +195.26% |
| 2020 | Rp154.62 Million | -7.07% |
| 2019 | Rp166.39 Million | +63.33% |
| 2018 | Rp101.87 Million | -37.15% |
| 2017 | Rp162.09 Million | -36.21% |
| 2016 | Rp254.09 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Prodia Widyahusada Tbk PT was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $141.18 Million USD |
| MoneyControl | $141.18 Million USD |
| MarketWatch | $141.18 Million USD |
| marketcap.company | $141.18 Million USD |
| Reuters | $141.18 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.